MAOA and pancreatic ductal adenocarcinoma: In a pancreatic ductal adenocarcinoma (PDAC) study, elevated levels of TPH1 and decreased levels of monoamine oxidase A (MAOA), a serotonin‐degrading enzyme, were reported, correlating with tumour stage, size and poor prognosis.